GLIMEPIRIDE + METFORMIN Manufacturer Supplier in PCD Pharma Franchise
![](https://matinspharma.com/wp-content/uploads/2024/03/Glimsu-M2-PhotoRoom.png-PhotoRoom-1030x803.png)
BRAND NAME FOR GLIMEPIRIDE+ METFORMIN IN PCD PHARMA FRANCHISE – GLIMSU – M2
COMPOSITION: Glimepiride (2mg) + Metformin (500mg)
For rates and Schemes – Contact 8284010553
Introduction of GLIMEPIRIDE + METFORMIN
GLIMSU – M2, manufactured by Matins Pharma, is a combination medication containing Glimepiride (2mg) and Metformin (500mg). Glimepiride belongs to the sulfonylurea class of antidiabetic drugs, while Metformin is a biguanide. This combination is used for the treatment of type 2 diabetes mellitus to help control blood sugar levels effectively.
making a significant impact on the lives of patients.
Uses of GLIMEPIRIDE+ METFORMIN
- Diabetes Management: GLIMSU – M2 is indicated for the management of type 2 diabetes mellitus. Glimepiride stimulates insulin secretion from pancreatic beta cells, while Metformin improves insulin sensitivity in peripheral tissues and reduces hepatic glucose production. Together, they help lower blood glucose levels and improve glycemic control.
- Glycemic Control: By regulating blood sugar levels, GLIMSU – M2 helps prevent diabetes-related complications such as cardiovascular disease, neuropathy, nephropathy, and retinopathy. It plays a crucial role in achieving and maintaining optimal glycemic control in patients with diabetes.
Side Effects of GLIMEPIRIDE + METFORMIN
While GLIMSU – M2 is generally well-tolerated, it may cause some side effects in some individuals. Common side effects include:
– Gastrointestinal Upset: Mild gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal discomfort may occur, particularly with Metformin. These side effects are usually transient and can be minimized by taking the medication with meals.
– Hypoglycemia: Glimepiride can cause hypoglycemia (low blood sugar) when taken alone or in combination with other antidiabetic drugs. Symptoms of hypoglycemia include sweating, trembling, confusion, and palpitations.
– Lactic Acidosis: Although rare, Metformin can rarely cause a serious side effect called lactic acidosis, characterized by symptoms such as weakness, muscle pain, difficulty breathing, and abdominal discomfort. Patients should seek immediate medical attention if they experience these symptoms.
Safety Advice of GLIMEPIRIDE + METFORMIN
– Regular Monitoring: Patients taking GLIMSU – M2 should undergo regular monitoring of blood glucose levels to assess the effectiveness of treatment and detect hypoglycemia or hyperglycemia.
– Hypoglycemia Prevention: To minimize the risk of hypoglycemia, patients should follow a consistent meal plan, avoid skipping meals, and monitor blood sugar levels regularly. They should also be educated about the signs and symptoms of hypoglycemia and how to treat it promptly.
– Renal Function Monitoring: Since Metformin is excreted by the kidneys, renal function should be assessed before initiating treatment and periodically thereafter, particularly in patients with renal impairment or elderly patients.
Dosage of GLIMEPIRIDE + METFORMIN
The recommended starting dose of GLIMSU – M2 is one tablet once daily, taken with meals to reduce gastrointestinal side effects. The dosage may be adjusted based on the patient’s glycemic response, with a maximum recommended dose of four tablets daily.
The onset of action of GLIMSU – M2 varies depending on individual patient factors and the specific formulation of Metformin. Glimepiride typically starts working within a few hours of administration, while Metformin may take several days to weeks to achieve its full therapeutic effect on blood glucose levels. Patients should continue taking GLIMSU – M2 as prescribed by their healthcare provider and follow up regularly for monitoring and dose adjustments as needed.
MATINS PHARMA IS A LEADING MANUFACTURER / SUPPLIER OF GLIMEPIRIDE + METFORMIN
In conclusion, Matins Pharma, a leading manufacturer and supplier in the pharmaceutical industry, offers high-quality GLIMEPIRIDE + METFORMIN under the brand name GLIMSU – M2.
Matins Pharma is one of the fastest growing Manufacturers suppliers pan India.
WE AT MATINS PHARMA AIM FOR :
- 100% quality assurance with high efficacy and excellent results
- Improved delivery experience and shorter delivery times
- Best in class service levels through regular communication with our Supplier partners and sharing the same in a transparent manner
- Customer satisfaction and understanding the latent needs of the our business partners
- Enriching our product mix by each passing day so as to provide you everything under one roof
Why Matins Pharma is among the best PCD Pharma Franchise Company in India:
- 100 % Quality Assurance
- Direct Dealing with Company Owners
- Very High Efficacy, WHO/GMP/GLP Certified Products
- Wide Product Range
- Best in Class Packings with UV Drip Off Finish
- High Margin Products with genuine rates
- Same Day Dispatch with trusted delivery partners
- Fair and Transparent Dealing – 100 % Commitment to agreement
Address: D-1A, Ahluwalia Complex Vill. Fatehpur, Sector 20, Panchkula, 134117, Haryana
Contact Number: 82840 10553, 99155 69932, 94175 06219India
We at Matins Pharma provide wide range of quality products. We offer the following ranges in PCD Pharma Franchise:
About Us
Matins Pharma is one of the fastest growing PCD Pharma company in the Indian Pharma Industry. We made foray into the pharma business in 1996 and entered the PCD domain in 2014. We have been supplying finished pharma supplies under PCD franchise model for past 5 years and we have had excellent results.
Our Office Hours
Mo-Fr: 8:00-19:00
Sa: 8:00-14:00
So: closed
Contact Info
Mr. Rakesh Kansal
Phone:-(91)-8284010553
Phone:-(91)-9417506219
SCO: D-1A, Ahluwalia Complex
Vill. Fatehpur, Sector 20
Panchkula – 134117
Haryana